Bortezomib sensitizers identified in KMS11
Gene ID . | No. of siRNA . | GEP . | Gene ID . | No. of siRNA . | GEP . |
---|---|---|---|---|---|
BAZ1B | 2 | P | PSMB7 | 3 | P |
CCNK | 2 | ND | RAB 8B | 3 | P |
CDC42SE2 | 3 | P | RB1CC1 | 2 | P |
CDK5 | 2 | P | STK6 | 2 | P |
CEBPA | 2 | P | TFAP4 | 2 | P |
CHD4 | 2 | P | TFE3 | 2 | P |
CRKL | 3 | P | TNFAIP3 | 4 | P |
CTNNB1 | 2 | P | TNK1 | 2 | P |
DCAMKL1 | 2 | ND | TOP1 | 2 | P |
ENC1 | 2 | P | USP8 | 2 | P |
MAST2 | 2 | P | VAMP2 | 3 | P |
MDM4 | 2 | P | VBP1 | 2 | P |
MIF | 2 | P | VDAC3 | 2 | P |
NCOR1 | 2 | P | WTAP | 3 | P |
NME7 | 2 | P | XPC | 2 | P |
OGT | 2 | P | XRCC5 | 2 | P |
PSMA5 | 3 | P | YY1 | 3 | P |
PSMB2 | 4 | P | ZNF197 | 2 | P |
PSMB3 | 4 | P |
Gene ID . | No. of siRNA . | GEP . | Gene ID . | No. of siRNA . | GEP . |
---|---|---|---|---|---|
BAZ1B | 2 | P | PSMB7 | 3 | P |
CCNK | 2 | ND | RAB 8B | 3 | P |
CDC42SE2 | 3 | P | RB1CC1 | 2 | P |
CDK5 | 2 | P | STK6 | 2 | P |
CEBPA | 2 | P | TFAP4 | 2 | P |
CHD4 | 2 | P | TFE3 | 2 | P |
CRKL | 3 | P | TNFAIP3 | 4 | P |
CTNNB1 | 2 | P | TNK1 | 2 | P |
DCAMKL1 | 2 | ND | TOP1 | 2 | P |
ENC1 | 2 | P | USP8 | 2 | P |
MAST2 | 2 | P | VAMP2 | 3 | P |
MDM4 | 2 | P | VBP1 | 2 | P |
MIF | 2 | P | VDAC3 | 2 | P |
NCOR1 | 2 | P | WTAP | 3 | P |
NME7 | 2 | P | XPC | 2 | P |
OGT | 2 | P | XRCC5 | 2 | P |
PSMA5 | 3 | P | YY1 | 3 | P |
PSMB2 | 4 | P | ZNF197 | 2 | P |
PSMB3 | 4 | P |
Bortezomib sensitizers were defined as genes targeted by at least 2 distinct siRNAs that decrease EC50 by 2 SDs from the EC50 of cells treated with control siRNAs. After excluding the genes that have absent call in KMS11 GEP, 37 targets were selected. Gene symbol (Gene ID), number of sensitizing siRNA, and expression status in GEP are presented for each hit.
GEP indicates gene expression profile; and P, present call.